$1\mathrm{.}13$ Value Chain Analysis and Financial Statement Relations.

Exhibit $1\mathrm{.}18$ represents common$-$size income statements and balance sheets for seven firms that operate at various stages in the value chain for the pharmaceutical industry. These common$-$size statements express all amounts as a percentage of sales revenue. Exhibit $1\mathrm{.}18$ also shows the cash flow from operations to capital expenditures ratios for each firm. A dash for a particular financial statement item does not necessarily mean the amount is zero. It merely indicates that the amount is not sufficiently large for the firm to disclose it$.$

Below, use the ratios to match the companies in Exhibit $1\mathrm{.}18$ with the firms listed.